CHEK2 and breast carcinoma: Germline CHEK2 variants have now been identified in ~ 1% of the population [9], and pathogenic variants (PVs) are causally linked to multiple types of cancer, including colon cancer and breast cancer (BC), further highlighting the functional relevance of CHEK2 in safeguarding genome integrity [3] [10].